In therian mammals, the X-chromosome is present as two copies in female cells while one copy in male cells. The X and Y-chromosomes evolved from an ancestral autosomal pair on which the genetic sexdetermining factor Sry appeared around 166 million years ago 1 . To preserve genetic linkage between Sry and Y-linked male-beneficial genes, Y-X recombination was repressed, leading to Y-chromosome degeneration and gene loss over time 2 . This rendered males monosomic for X-linked gene products and thus imbalanced with the diploid autosomal (A) part of the genome. Landmark theoretical work 3 by Susumo Ohno proposed that cells restore X:AA balance by doubling the expression of chromosome X, resulting in the X:AA expression ratio of 1 (analogous to X:A ratio 2). This concept ( Figure  1a ) is termed Ohno's hypothesis, and the emergence of this compensatory process is presumed to predate the evolution of Xchromosome inactivation 4 (XCI) by which female cells silence one Xchromosome to reach male-equivalent expression levels for X-linked genes.
Several studies have reported X-upregulation in mammals, initially using microarrays 5, 6 and later using RNA-sequencing 7, 8 . But the validity of Ohno's hypothesis has also been contested [9] [10] [11] , and a caveat to bulk analysis is that cellular heterogeneity may skew estimates due to cell subpopulations expressing chromosomes unequally 7 . Emerging scRNAseq technology provides the opportunity to asses X:A dose balance at the level of the actual regulatory system (i.e. the cell); but dedicated scRNAseq studies are so far few [11] [12] [13] [14] , and some arrived at opposite conclusions regarding X-upregulation from the very same scRNAseq data 11, 12 . Moreover, a fundamental limitation in all present scRNAseq analyses is that they lack unique molecular identifiers (UMIs) needed to avoid library amplification bias (which is particularly severe for scRNAseq cross-gene comparisons) 15 , or, lack the full-length read coverage of transcripts needed for allele-specific and single-gene-copy analysis. Finally, eukaryotic gene expression occurs through episodic bursting of RNA synthesis [16] [17] [18] [19] , but kinetic studies of X-upregulation are completely lacking. Here, we dissected X-upregulation using transcriptional kinetics, providing mechanistic insight to this process.
We investigated primary female fibroblasts (n=224) and male embryonic stem cells (ESCs, n=188) from outbred mice (hybrids of CAST/EiJ and C57BL/6J) that were subjected to full-length scRNAseq with UMIs 18 (Online Methods). We recently developed methods to infer transcriptional burst parameters individually for each gene copy 18 using the two-state model of transcription 20 , providing allelespecific estimates of burst frequency (kon) and burst size (ksyn/koff) (Figure 1b-c) . In order to explore the kinetics of X-upregulation, we first segregated female fibroblasts expressing either the maternal (CAST, n=172) or paternal (C57, n=52) X-chromosome due to random XCI. Expectedly, male ESCs (n=188) transcribed exclusively the maternal X-allele (Figure 1d-e) . To investigate X-chromosome expression per cell, we first counted mRNAs de facto present in the individual cells (i.e. ≥1 UMI) and calculated cellular expression levels for genes on the active X and autosomal chromosomes. Strikingly, cellular X-chromosome RNA levels were higher than those of autosomes within the same cells (P≤ 1.2x10 -9 , paired Wilcoxon ranksum test) (Figure 2a) . To avoid possible confoundment of few highexpressed genes dominating chromosomal expression estimates we excluded genes beyond the 95 th percentile of expression levels per cell. Other thresholds such as the 90 th and 99 th percentile provided similar results (Figure 2b ) and the X:A difference was significant across a wide span of thresholds (Figure 2c) . Next, we determined gene-wise expression-level distributions for chromosome X (n=149 genes, fibroblast C57 allele) and autosomes (n=3790 genes, fibroblast C57 allele), including only expressed genes (average ≥1 UMI detected per cell) that also had robustly inferable kinetic parameters (Online Methods). This revealed a positively shifted expression-level distribution for X-linked genes (median fold-change: 1.4, P= 4,2x10 -5 , two-sided Wilcoxon test; fibroblast C57 allele) (Figure 2d-e) . Comparing distributions for all chromosomes, we observed such a shift to be unique for chromosome X (Figure 2f-g ). These results were replicated over the fibroblast CAST allele and male ESCs ( Supplementary Figure 1-2) . This confirms Ohno's hypothesis.
In the two-state model of transcription, expression levels are determined by (1) the fraction of time the gene spends in transcriptional on-state, generating a burst of RNA copies; (2) the average number of RNA molecules synthesised during such a burst; and (3) the degradation rate of RNA (Figure 1b-c) . We compared burst frequencies (kon) for chromosome X and autosomes. Intriguingly, X-chromosome genes maintained distinctly elevated burst frequencies (median fold-change: 1.5, P= 3.3x10 -7 , Wilcoxon test, fibroblast C57 allele, Figure 3a-d) . This was validated over the fibroblasts CAST allele as well as in male ESCs (P= 3.7x10 -6 and 1.1x 10 -7 , respectively) ( Supplementary Figure 1-2) . Next, we performed 2 similar analyses for burst sizes (ksyn/koff) and observed the lack of significant difference between chromosome X and autosomes (P= 0.93; power: 99%, Figure 3e -h and Supplementary Figure 1-3) . To confirm that these kinetic features were not unique for fibroblast-or ESC-specific transcripts, we repeated the analyses using housekeeping genes (Online Methods) (Supplementary Figure 4) . Altogether, our results imply that X-chromosome upregulation occurs through increased frequency of transcriptional bursting in both female and male cells. Previous studies 21, 22 found that X-chromosome transcripts tended to have longer RNA half-lives than those of autosomes, suggesting that lowered decay rates contribute to dosage compensation. We used metabolic-RNA-labelling data from mouse ESCs (Online Methods), and investigated RNA decay rates for X-linked and autosomal genes. This indeed confirmed lowered decay rates for Xchromosome transcripts (P≤ 1.3x10 -4 , Figure 3i ). However, we also observed the general trend that expression levels negatively correlated with decay rates independently of chromosomal origin of RNAs (Spearman correlation -0.38 and -0.35; P= 9.9x10 -5 and P= 1.0x10 -79 for X and autosomal genes, respectively; Figure 3i ). We tested whether X-genes had lowered decay rates given their expression levels by calculating the distribution of decay rates for autosomal genes of same expression levels. X-chromosome genes and matched autosomal genes had similar decay rates (medians 0.15 and 0.15, P= 0.50, paired Wilcoxon test) (Figure 3i ). This does not conflict that increased RNA stability might contribute to dosage compensation, but does motivate the search for X-specific regulatory features. We reasoned that if increased burst frequency is a key mechanism to achieve X-upregulation, a shifted burst-frequency distribution might be detectable even when compared to autosomal genes of matched expression levels, albeit expectedly with a smaller shift since the autosomal expression distribution would artificially be shifted to higher values. Indeed, this was valid for both fibroblast alleles as well as for ESCs (P= 0.039; 7.6x10 -5 ; 1.9x10 -4 , respectively; paired one-sided Wilcoxon test) (Figure 4j- 
k).
Here we investigated X-chromosome upregulation at the resolution of transcriptional kinetics for the first time. Using scRNA-seq data with both full-transcript coverage and UMIs, we simultaneously obtained precise estimates of expression levels and detailed allelespecific information for single-gene-copy inferences. Analysing these novel data, we confirmed the validity of Ohno's hypothesis by detecting positively shifted expression-level distributions for chromosome X both at cellular and gene-wise level (Figure 2 and Supplementary Figure 1a-b) . The observed ~1.4-fold change of X:A levels (Figure 2c and Supplementary Figure 1-2) rather than the theoretical 2-fold change suggests that not all X-linked genes attained dosage compensation, or that less than 2-fold upregulation is adequate to achieve sufficient X:A balance for most genes.
While XCI has been extensively explored, providing profound insights into gene silencing, mechanistic correlates to mammalian Xupregulation are few 13, 21, 22 . By breaking down expression levels into kinetic parameters of transcription, we showed for the first time that dosage compensation is achieved by increased burst frequencies on chromosome X. Since burst frequencies are preferentially encoded in enhancer elements 18 , it is likely that the increased transcriptional output from the X-chromosome is due to trans-acting factors affecting enhancers. Moreover, such factors would preferentially target enhancers located on the X-chromosome.
Methods
Sequencing and classification of expressed X-chromosome allele in each cell. A modified version of Smartseq2 23, 24 was used to sequence the transcriptomes of primary mouse tail fibroblasts (n=224) and ESCs (n=188), as described in Larsson et. al. 18 . In brief, we utilized a modified Smartseq2 strand-switch primer containing a UMI (6-base random sequence). Sequencing was performed on an Illumina Nextseq 500, and sequence reads were mapped to the C57 and CAST genomes, and reads spanning strain-specific SNPs were counted as described previously 18, 25, 26 . The sequencing data is available at E-MTAB-7098. In order to classify cells as either having the C57 or the CAST X-chromosome active in the female fibroblasts, due to Xinactivation, we calculated the aggregated expression of all genes and alleles on the X-chromosome and compared the sums. The parental X-chromosome with the higher sum was classified as having that allele active. In addition, we calculated the fraction of maternal RNA as shown in Figure 1e to further verify this classification. All male ESCs expressed only the maternal X chromosome, as these cells carry only one X-chromosome copy.
Inference of transcriptional kinetics parameters. In the model of transcription used, a gene switches to the on state and off state at exponentially distributed times with rates and respectively. When the gene is on, RNA is produced at rate . Regardless of gene state, the RNA is degraded with rate . In brief, the probability distribution for the steady state of the stochastic process illustrated in Figure 1b is the Beta-Poisson compound probability distribution. The parameters of this process were estimated in the time scale of degradation ( ) by maximum likelihood. Detailed information regarding the inference procedure is described in Larsson et. al. 18 . For cells in which the C57 X-chromosome allele was active, we inferred the parameter for autosomal genes at the C57 allele in the same cells (n fibroblasts C57= 52, n ESCs C57= 188). For cells in which the CAST X-chromosome allele was active, we inferred the parameter for autosomal genes at the CAST allele in the same cells (n cells fibroblast CAST= 172). RNA decay rates were obtained for mouse ECSs from Supplementary Table 1 of Herzog et. al. 27 .
Comparisons between chromosomes.
In all comparisons, we included genes that were expressed (≥1 UMI) in the given cells and that also had robustly inferable kinetic parameters (defined as: within the bounds of the maximum likelihood procedure (10 −3 < , < 10 3 and 1 < < 10 4 ) and biologically feasible ( > 1)). For the cell-wise analysis of chromosome expression levels (Figure 2a) we included genes that were detected (at least 1 UMI) in each individual cell and excluded genes beyond the 95 th percentile of expression levels per cell. We calculated the mean expression level for each chromosome in each individual cell and divided these values by the mean expression of all autosomal genes in the individual cells (resulting in normalized cellular ChrN/ChrA values). We repeated the analysis using different upper expression thresholds, and cellular X:A differences were significant even when 3 excluding as much as the upper 50% of genes (Figure 2c) . To compare gene-wise expression levels between chromosome X and autosomes, we calculated the mean expression for each gene across the cells of given cell-type and genotype (C57 allele in cells having the C57-Xchromosome active, and CAST allele in cells having the CAST-Xchromosome active) and plotted a smoother kernel density. To assess the probability of drawing a set of genes with a median equal to or higher than that of X-linked genes from the autosomal distribution, we randomly subsampled autosomal genes (n= n[X-linked genes]; e.g. 149 in case of fibroblast C57 allele) and calculated the median expression level. This was repeated 100,000 times (Figure  2e) , and we calculated the fraction (f) permutations for which the median of the random autosomal subset equated or exceeded the median of chromosome X. Corresponding analyses were performed for burst frequency (kon), and burst size (ksyn/koff). To assess the differences between chromosomes in mean expression (UMIs per cell), burst frequency, and burst size, we used the Wilcoxon rank-sum test as specified in the figure legends for each comparison.
Housekeeping genes used in Supplementary figure 4 were ubiquitously expressed genes 28 (genes expressed across 17 mouse tissues).
Power analysis of detecting X-chromosome wide upregulation in burst size. To assess whether we would have the power to detect a 1.4x change in expression level due to burst size, we randomly selected 149 autosomal genes, increased their burst size by 1.4, used the Wilcoxon rank-sum test and noted the P-value of this test. This was repeated 1000 times.
Code availability. The computational code used for calculations and plotting of data are available at https://sourceforge.net/projects/ kinetics-of-x-upregulation. Wilcoxon rank-sum test was used for significance tes�ng. (e) Histogram of median expression levels of randomly subsampled autosomal genes compared to the median of X-linked genes (n=149 genes; 100,000 permuta�ons), and f deno�ng frac�on permuta�ons for which the autosomal median reached that of chromosome X. (f) Distribu�on of expression levels for genes on each autosomal chromosome (light blue), all autosomes (dark blue), and chromosome X (red). Centre lines denote the median; hinges denote the first and third quar�les; whiskers denote 1.5×IQR. One-sided Wilcoxon rank-sum test was used for significance tes�ng. (g) Heatmap of P-values from all pairwise comparisons of expression levels between chromosomes using two-sided Wilcoxon rank sum test. -log 10 (P) Top right: Correla�ons between RNA decay rate and mean expression level (n=2690 autosomal and 99 X-linked genes, spearman correla�on). Bo�om: Distribu�ons of expression levels for autosomal, X-linked and expression-matched autosomal genes. Centre lines denote the median; hinges denote the first and third quar�les; whiskers denote 1.5×IQR. One-sided Wilcoxon rank-sum test used for significance tes�ng. (j) Distribu�on of burst frequency for X-chromosome (red) and autosomal genes of matched (nearest) expression value, shown for each allele in fibroblasts and the C57 allele for ESCs. Paired one-sided Wilcoxon rank-sum test was used for significance tes�ng between expression matched autosomal and X-genes.
